nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Basal cell carcinoma—Octreotide—thymus cancer	0.0276	0.0288	CcSEcCtD
Rivastigmine—BCHE—diaphragm—thymus cancer	0.0214	0.539	CbGeAlD
Rivastigmine—Goitre—Octreotide—thymus cancer	0.0182	0.019	CcSEcCtD
Rivastigmine—Varicose vein—Octreotide—thymus cancer	0.0175	0.0182	CcSEcCtD
Rivastigmine—Rectal tenesmus—Octreotide—thymus cancer	0.0175	0.0182	CcSEcCtD
Rivastigmine—Hypochromic anaemia—Octreotide—thymus cancer	0.0168	0.0175	CcSEcCtD
Rivastigmine—Prostatic disorder—Octreotide—thymus cancer	0.0153	0.016	CcSEcCtD
Rivastigmine—Stomach ache—Octreotide—thymus cancer	0.0153	0.016	CcSEcCtD
Rivastigmine—Ulcerative stomatitis—Octreotide—thymus cancer	0.0141	0.0147	CcSEcCtD
Rivastigmine—Hernia—Octreotide—thymus cancer	0.0139	0.0145	CcSEcCtD
Rivastigmine—Proctalgia—Octreotide—thymus cancer	0.0139	0.0145	CcSEcCtD
Rivastigmine—Trauma—Octreotide—thymus cancer	0.0137	0.0142	CcSEcCtD
Rivastigmine—Rectal disorder—Octreotide—thymus cancer	0.0133	0.0138	CcSEcCtD
Rivastigmine—Appetite absent—Octreotide—thymus cancer	0.0131	0.0136	CcSEcCtD
Rivastigmine—Anorectal disorder—Octreotide—thymus cancer	0.0124	0.0129	CcSEcCtD
Rivastigmine—Ear disorder—Octreotide—thymus cancer	0.0121	0.0126	CcSEcCtD
Rivastigmine—Anorectal discomfort—Octreotide—thymus cancer	0.0119	0.0124	CcSEcCtD
Rivastigmine—Cholecystitis—Octreotide—thymus cancer	0.0113	0.0118	CcSEcCtD
Rivastigmine—Multiple fractures—Octreotide—thymus cancer	0.0112	0.0117	CcSEcCtD
Rivastigmine—Fracture—Octreotide—thymus cancer	0.0112	0.0117	CcSEcCtD
Rivastigmine—Haemorrhoids—Octreotide—thymus cancer	0.0111	0.0115	CcSEcCtD
Rivastigmine—Cholelithiasis—Octreotide—thymus cancer	0.0105	0.0109	CcSEcCtD
Rivastigmine—Haematoma—Octreotide—thymus cancer	0.0104	0.0108	CcSEcCtD
Rivastigmine—Hypothyroidism—Octreotide—thymus cancer	0.0101	0.0106	CcSEcCtD
Rivastigmine—Nail disorder—Octreotide—thymus cancer	0.01	0.0105	CcSEcCtD
Rivastigmine—Peptic ulcer—Octreotide—thymus cancer	0.00974	0.0101	CcSEcCtD
Rivastigmine—Paranoia—Octreotide—thymus cancer	0.00955	0.00995	CcSEcCtD
Rivastigmine—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00955	0.00995	CcSEcCtD
Rivastigmine—Intestinal obstruction—Octreotide—thymus cancer	0.00955	0.00995	CcSEcCtD
Rivastigmine—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.00946	0.00985	CcSEcCtD
Rivastigmine—Neuralgia—Octreotide—thymus cancer	0.00937	0.00976	CcSEcCtD
Rivastigmine—Metrorrhagia—Octreotide—thymus cancer	0.00912	0.00949	CcSEcCtD
Rivastigmine—Influenza-like symptoms—Octreotide—thymus cancer	0.00912	0.00949	CcSEcCtD
Rivastigmine—Herpes zoster—Octreotide—thymus cancer	0.00865	0.00901	CcSEcCtD
Rivastigmine—Otitis media—Octreotide—thymus cancer	0.00837	0.00871	CcSEcCtD
Rivastigmine—Coagulopathy—Octreotide—thymus cancer	0.00837	0.00871	CcSEcCtD
Rivastigmine—Nephrolithiasis—Octreotide—thymus cancer	0.0081	0.00844	CcSEcCtD
Rivastigmine—Stinging—Octreotide—thymus cancer	0.00804	0.00837	CcSEcCtD
Rivastigmine—Neoplasm malignant—Octreotide—thymus cancer	0.00763	0.00794	CcSEcCtD
Rivastigmine—Breast pain—Octreotide—thymus cancer	0.00746	0.00777	CcSEcCtD
Rivastigmine—Rectal haemorrhage—Octreotide—thymus cancer	0.00721	0.00751	CcSEcCtD
Rivastigmine—Viral infection—Octreotide—thymus cancer	0.00721	0.00751	CcSEcCtD
Rivastigmine—Arthropathy—Octreotide—thymus cancer	0.00716	0.00746	CcSEcCtD
Rivastigmine—Cellulitis—Octreotide—thymus cancer	0.00716	0.00746	CcSEcCtD
Rivastigmine—Herpes simplex—Octreotide—thymus cancer	0.00707	0.00736	CcSEcCtD
Rivastigmine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00651	0.00678	CcSEcCtD
Rivastigmine—Vaginal inflammation—Octreotide—thymus cancer	0.00651	0.00678	CcSEcCtD
Rivastigmine—Eructation—Octreotide—thymus cancer	0.0064	0.00666	CcSEcCtD
Rivastigmine—Cystitis noninfective—Octreotide—thymus cancer	0.00636	0.00662	CcSEcCtD
Rivastigmine—Influenza like illness—Octreotide—thymus cancer	0.00632	0.00659	CcSEcCtD
Rivastigmine—Cystitis—Octreotide—thymus cancer	0.00629	0.00655	CcSEcCtD
Rivastigmine—Candida infection—Octreotide—thymus cancer	0.00622	0.00647	CcSEcCtD
Rivastigmine—Vaginal infection—Octreotide—thymus cancer	0.00615	0.0064	CcSEcCtD
Rivastigmine—Neuropathy—Octreotide—thymus cancer	0.00611	0.00637	CcSEcCtD
Rivastigmine—Cramps of lower extremities—Octreotide—thymus cancer	0.00598	0.00623	CcSEcCtD
Rivastigmine—Urine output increased—Octreotide—thymus cancer	0.00589	0.00613	CcSEcCtD
Rivastigmine—Bladder pain—Octreotide—thymus cancer	0.00589	0.00613	CcSEcCtD
Rivastigmine—Mouth ulceration—Octreotide—thymus cancer	0.00589	0.00613	CcSEcCtD
Rivastigmine—Hyperkinesia—Octreotide—thymus cancer	0.00568	0.00591	CcSEcCtD
Rivastigmine—Phlebitis—Octreotide—thymus cancer	0.00549	0.00571	CcSEcCtD
Rivastigmine—Thrombophlebitis—Octreotide—thymus cancer	0.00546	0.00569	CcSEcCtD
Rivastigmine—Sleep disorder—Octreotide—thymus cancer	0.00546	0.00569	CcSEcCtD
Rivastigmine—Diabetes mellitus—Octreotide—thymus cancer	0.00544	0.00566	CcSEcCtD
Rivastigmine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00544	0.00566	CcSEcCtD
Rivastigmine—Polyuria—Octreotide—thymus cancer	0.00538	0.00561	CcSEcCtD
Rivastigmine—Gastroenteritis—Octreotide—thymus cancer	0.00533	0.00555	CcSEcCtD
Rivastigmine—Deafness—Octreotide—thymus cancer	0.00528	0.0055	CcSEcCtD
Rivastigmine—Injury—Octreotide—thymus cancer	0.00514	0.00536	CcSEcCtD
Rivastigmine—Hot flush—Octreotide—thymus cancer	0.00505	0.00526	CcSEcCtD
Rivastigmine—Amnesia—Octreotide—thymus cancer	0.00503	0.00524	CcSEcCtD
Rivastigmine—Menopausal symptoms—Octreotide—thymus cancer	0.00501	0.00522	CcSEcCtD
Rivastigmine—Arthritis—Octreotide—thymus cancer	0.00486	0.00507	CcSEcCtD
Rivastigmine—Hypoglycaemia—Octreotide—thymus cancer	0.00484	0.00504	CcSEcCtD
Rivastigmine—Osteoarthritis—Octreotide—thymus cancer	0.00473	0.00492	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00473	0.00492	CcSEcCtD
Rivastigmine—Pain in extremity—Octreotide—thymus cancer	0.00473	0.00492	CcSEcCtD
Rivastigmine—Psychotic disorder—Octreotide—thymus cancer	0.00462	0.00481	CcSEcCtD
Rivastigmine—Dehydration—Octreotide—thymus cancer	0.0044	0.00458	CcSEcCtD
Rivastigmine—Dry skin—Octreotide—thymus cancer	0.00433	0.00451	CcSEcCtD
Rivastigmine—Abdominal pain upper—Octreotide—thymus cancer	0.00432	0.0045	CcSEcCtD
Rivastigmine—Cramp muscle—Octreotide—thymus cancer	0.00426	0.00443	CcSEcCtD
Rivastigmine—Nasopharyngitis—Octreotide—thymus cancer	0.00423	0.0044	CcSEcCtD
Rivastigmine—Gastritis—Octreotide—thymus cancer	0.00418	0.00436	CcSEcCtD
Rivastigmine—Muscular weakness—Octreotide—thymus cancer	0.00417	0.00434	CcSEcCtD
Rivastigmine—Bronchospasm—Octreotide—thymus cancer	0.00402	0.00418	CcSEcCtD
Rivastigmine—Pancreatitis—Octreotide—thymus cancer	0.00401	0.00417	CcSEcCtD
Rivastigmine—Sweating increased—Octreotide—thymus cancer	0.00398	0.00414	CcSEcCtD
Rivastigmine—Bronchitis—Octreotide—thymus cancer	0.00393	0.00409	CcSEcCtD
Rivastigmine—Dysuria—Octreotide—thymus cancer	0.00382	0.00398	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Octreotide—thymus cancer	0.0038	0.00395	CcSEcCtD
Rivastigmine—Pollakiuria—Octreotide—thymus cancer	0.00377	0.00393	CcSEcCtD
Rivastigmine—Weight increased—Octreotide—thymus cancer	0.00372	0.00387	CcSEcCtD
Rivastigmine—Weight decreased—Octreotide—thymus cancer	0.0037	0.00385	CcSEcCtD
Rivastigmine—Hyperglycaemia—Octreotide—thymus cancer	0.00369	0.00384	CcSEcCtD
Rivastigmine—Pneumonia—Octreotide—thymus cancer	0.00366	0.00382	CcSEcCtD
Rivastigmine—Drowsiness—Octreotide—thymus cancer	0.00364	0.00379	CcSEcCtD
Rivastigmine—Depression—Octreotide—thymus cancer	0.00363	0.00378	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Octreotide—thymus cancer	0.00357	0.00372	CcSEcCtD
Rivastigmine—Conjunctivitis—Octreotide—thymus cancer	0.00354	0.00369	CcSEcCtD
Rivastigmine—Urinary tract infection—Octreotide—thymus cancer	0.00354	0.00369	CcSEcCtD
Rivastigmine—Haematuria—Octreotide—thymus cancer	0.00347	0.00362	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Octreotide—thymus cancer	0.00345	0.00359	CcSEcCtD
Rivastigmine—Epistaxis—Octreotide—thymus cancer	0.00344	0.00358	CcSEcCtD
Rivastigmine—Sinusitis—Octreotide—thymus cancer	0.00342	0.00356	CcSEcCtD
Rivastigmine—Bradycardia—Octreotide—thymus cancer	0.00333	0.00347	CcSEcCtD
Rivastigmine—Rhinitis—Octreotide—thymus cancer	0.00328	0.00341	CcSEcCtD
Rivastigmine—Hepatitis—Octreotide—thymus cancer	0.00327	0.00341	CcSEcCtD
Rivastigmine—Hypoaesthesia—Octreotide—thymus cancer	0.00325	0.00339	CcSEcCtD
Rivastigmine—Pharyngitis—Octreotide—thymus cancer	0.00325	0.00338	CcSEcCtD
Rivastigmine—Oedema peripheral—Octreotide—thymus cancer	0.00322	0.00335	CcSEcCtD
Rivastigmine—Visual impairment—Octreotide—thymus cancer	0.00315	0.00328	CcSEcCtD
Rivastigmine—Tinnitus—Octreotide—thymus cancer	0.00305	0.00318	CcSEcCtD
Rivastigmine—Cardiac disorder—Octreotide—thymus cancer	0.00304	0.00316	CcSEcCtD
Rivastigmine—Flushing—Octreotide—thymus cancer	0.00304	0.00316	CcSEcCtD
Rivastigmine—Arrhythmia—Octreotide—thymus cancer	0.00292	0.00304	CcSEcCtD
Rivastigmine—ACHE—thyroid gland—thymus cancer	0.0029	0.0732	CbGeAlD
Rivastigmine—Alopecia—Octreotide—thymus cancer	0.00289	0.00301	CcSEcCtD
Rivastigmine—Mental disorder—Octreotide—thymus cancer	0.00287	0.00298	CcSEcCtD
Rivastigmine—Malnutrition—Octreotide—thymus cancer	0.00285	0.00296	CcSEcCtD
Rivastigmine—Erythema—Octreotide—thymus cancer	0.00285	0.00296	CcSEcCtD
Rivastigmine—Flatulence—Octreotide—thymus cancer	0.00281	0.00292	CcSEcCtD
Rivastigmine—Tension—Octreotide—thymus cancer	0.00279	0.00291	CcSEcCtD
Rivastigmine—Nervousness—Octreotide—thymus cancer	0.00277	0.00288	CcSEcCtD
Rivastigmine—Back pain—Octreotide—thymus cancer	0.00275	0.00287	CcSEcCtD
Rivastigmine—Muscle spasms—Octreotide—thymus cancer	0.00274	0.00285	CcSEcCtD
Rivastigmine—Vision blurred—Octreotide—thymus cancer	0.00268	0.00279	CcSEcCtD
Rivastigmine—Tremor—Octreotide—thymus cancer	0.00267	0.00278	CcSEcCtD
Rivastigmine—Ill-defined disorder—Octreotide—thymus cancer	0.00264	0.00275	CcSEcCtD
Rivastigmine—Anaemia—Octreotide—thymus cancer	0.00263	0.00274	CcSEcCtD
Rivastigmine—Agitation—Octreotide—thymus cancer	0.00262	0.00272	CcSEcCtD
Rivastigmine—Malaise—Octreotide—thymus cancer	0.00257	0.00267	CcSEcCtD
Rivastigmine—Vertigo—Octreotide—thymus cancer	0.00256	0.00266	CcSEcCtD
Rivastigmine—Syncope—Octreotide—thymus cancer	0.00255	0.00266	CcSEcCtD
Rivastigmine—Palpitations—Octreotide—thymus cancer	0.00252	0.00262	CcSEcCtD
Rivastigmine—Loss of consciousness—Octreotide—thymus cancer	0.0025	0.00261	CcSEcCtD
Rivastigmine—Cough—Octreotide—thymus cancer	0.00248	0.00259	CcSEcCtD
Rivastigmine—Convulsion—Octreotide—thymus cancer	0.00247	0.00257	CcSEcCtD
Rivastigmine—Hypertension—Octreotide—thymus cancer	0.00246	0.00256	CcSEcCtD
Rivastigmine—Chest pain—Octreotide—thymus cancer	0.00242	0.00252	CcSEcCtD
Rivastigmine—Myalgia—Octreotide—thymus cancer	0.00242	0.00252	CcSEcCtD
Rivastigmine—Arthralgia—Octreotide—thymus cancer	0.00242	0.00252	CcSEcCtD
Rivastigmine—Anxiety—Octreotide—thymus cancer	0.00242	0.00252	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00241	0.00251	CcSEcCtD
Rivastigmine—Discomfort—Octreotide—thymus cancer	0.00239	0.00249	CcSEcCtD
Rivastigmine—Dry mouth—Octreotide—thymus cancer	0.00237	0.00247	CcSEcCtD
Rivastigmine—Oedema—Octreotide—thymus cancer	0.00232	0.00242	CcSEcCtD
Rivastigmine—Infection—Octreotide—thymus cancer	0.00231	0.0024	CcSEcCtD
Rivastigmine—Shock—Octreotide—thymus cancer	0.00229	0.00238	CcSEcCtD
Rivastigmine—Nervous system disorder—Octreotide—thymus cancer	0.00228	0.00237	CcSEcCtD
Rivastigmine—Thrombocytopenia—Octreotide—thymus cancer	0.00227	0.00237	CcSEcCtD
Rivastigmine—Tachycardia—Octreotide—thymus cancer	0.00227	0.00236	CcSEcCtD
Rivastigmine—Skin disorder—Octreotide—thymus cancer	0.00226	0.00235	CcSEcCtD
Rivastigmine—Hyperhidrosis—Octreotide—thymus cancer	0.00225	0.00234	CcSEcCtD
Rivastigmine—BCHE—hematopoietic system—thymus cancer	0.00223	0.0562	CbGeAlD
Rivastigmine—Anorexia—Octreotide—thymus cancer	0.00221	0.00231	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00212	0.0022	CcSEcCtD
Rivastigmine—Insomnia—Octreotide—thymus cancer	0.0021	0.00219	CcSEcCtD
Rivastigmine—Paraesthesia—Octreotide—thymus cancer	0.00209	0.00217	CcSEcCtD
Rivastigmine—Dyspnoea—Octreotide—thymus cancer	0.00207	0.00216	CcSEcCtD
Rivastigmine—Somnolence—Octreotide—thymus cancer	0.00207	0.00215	CcSEcCtD
Rivastigmine—Dyspepsia—Octreotide—thymus cancer	0.00205	0.00213	CcSEcCtD
Rivastigmine—Decreased appetite—Octreotide—thymus cancer	0.00202	0.0021	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00201	0.00209	CcSEcCtD
Rivastigmine—Fatigue—Octreotide—thymus cancer	0.002	0.00209	CcSEcCtD
Rivastigmine—Pain—Octreotide—thymus cancer	0.00199	0.00207	CcSEcCtD
Rivastigmine—Constipation—Octreotide—thymus cancer	0.00199	0.00207	CcSEcCtD
Rivastigmine—Feeling abnormal—Octreotide—thymus cancer	0.00191	0.00199	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Octreotide—thymus cancer	0.0019	0.00198	CcSEcCtD
Rivastigmine—Urticaria—Octreotide—thymus cancer	0.00185	0.00192	CcSEcCtD
Rivastigmine—Abdominal pain—Octreotide—thymus cancer	0.00184	0.00191	CcSEcCtD
Rivastigmine—Body temperature increased—Octreotide—thymus cancer	0.00184	0.00191	CcSEcCtD
Rivastigmine—ACHE—lymph node—thymus cancer	0.0018	0.0454	CbGeAlD
Rivastigmine—Hypersensitivity—Octreotide—thymus cancer	0.00171	0.00178	CcSEcCtD
Rivastigmine—BCHE—cardiac atrium—thymus cancer	0.00169	0.0427	CbGeAlD
Rivastigmine—Asthenia—Octreotide—thymus cancer	0.00167	0.00174	CcSEcCtD
Rivastigmine—BCHE—pituitary gland—thymus cancer	0.00165	0.0417	CbGeAlD
Rivastigmine—Pruritus—Octreotide—thymus cancer	0.00164	0.00171	CcSEcCtD
Rivastigmine—Diarrhoea—Octreotide—thymus cancer	0.00159	0.00166	CcSEcCtD
Rivastigmine—Dizziness—Octreotide—thymus cancer	0.00154	0.0016	CcSEcCtD
Rivastigmine—CYP3A4—hematopoietic system—thymus cancer	0.0015	0.0379	CbGeAlD
Rivastigmine—Vomiting—Octreotide—thymus cancer	0.00148	0.00154	CcSEcCtD
Rivastigmine—CYP2D6—hematopoietic system—thymus cancer	0.00148	0.0373	CbGeAlD
Rivastigmine—Rash—Octreotide—thymus cancer	0.00147	0.00153	CcSEcCtD
Rivastigmine—Dermatitis—Octreotide—thymus cancer	0.00146	0.00152	CcSEcCtD
Rivastigmine—Headache—Octreotide—thymus cancer	0.00146	0.00152	CcSEcCtD
Rivastigmine—BCHE—bone marrow—thymus cancer	0.00143	0.0361	CbGeAlD
Rivastigmine—BCHE—thyroid gland—thymus cancer	0.00143	0.036	CbGeAlD
Rivastigmine—Nausea—Octreotide—thymus cancer	0.00138	0.00144	CcSEcCtD
Rivastigmine—BCHE—lung—thymus cancer	0.00129	0.0327	CbGeAlD
Rivastigmine—BCHE—lymph node—thymus cancer	0.000886	0.0223	CbGeAlD
